Suppr超能文献

早期肠内营养对患有严重细小病毒性肠炎的犬肠道通透性、肠道蛋白质丢失及预后的影响。

Effect of early enteral nutrition on intestinal permeability, intestinal protein loss, and outcome in dogs with severe parvoviral enteritis.

作者信息

Mohr Albert J, Leisewitz Andrew L, Jacobson Linda S, Steiner Jörg M, Ruaux Craig G, Williams David A

机构信息

Department of Companion Animal Clinical Studies, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa.

出版信息

J Vet Intern Med. 2003 Nov-Dec;17(6):791-8. doi: 10.1111/j.1939-1676.2003.tb02516.x.

Abstract

A randomized, controlled clinical trial investigated the effect of early enteral nutrition (EN) on intestinal permeability, intestinal protein loss, and outcome in parvoviral enteritis. Dogs were randomized into 2 groups: 15 dogs received no food until vomiting had ceased for 12 hours (mean 50 hours after admission; NPO group), and 15 dogs received early EN by nasoesophageal tube from 12 hours after admission (EEN group). All other treatments were identical. Intestinal permeability was assessed by 6-hour urinary lactulose (L) and rhamnose (R) recoveries (%L, %R) and L/R recovery ratios. Intestinal protein loss was quantified by fecal alpha1-proteinase inhibitor concentrations (alpha1-PI). Median time to normalization of demeanor, appetite, vomiting, and diarrhea was 1 day shorter for the EEN group for each variable. Body weight increased insignificantly from admission in the NPO group (day 3: 2.5 +/- 2.8%; day 6: 4.3 +/- 2.3%; mean +/- SE), whereas the EEN group exhibited significant weight gain (day 3: 8.1 +/- 2.7%; day 6: 9.7 +/- 2.1%). Mean urinary %L was increased, %R reduced, and L/R recovery ratios increased compared to reference values throughout the study for both groups. Percent lactulose recovery decreased in the EEN group (admission: 22.6 +/- 8.0%; day 6: 17.9 +/- 2.3%) and increased in the NPO group (admission: 11.0 +/- 2.6%; day 6: 22.5 +/- 4.6%, P = .035). Fecal alpha1-PI was above reference values in both groups and declined progressively. No significant differences occurred for %R, L/R ratios, or alpha1-PI between groups. Thirteen NPO dogs and all EEN dogs survived (P = .48). The EEN group showed earlier clinical improvement and significant weight gain. The significantly decreased %L in the EEN versus NPO group might reflect improved gut barrier function, which could limit bacterial or endotoxin translocation.

摘要

一项随机对照临床试验研究了早期肠内营养(EN)对细小病毒性肠炎肠道通透性、肠道蛋白质丢失及预后的影响。将犬随机分为2组:15只犬在呕吐停止12小时之前不给予食物(入院后平均50小时;禁食组),15只犬在入院12小时后通过鼻饲管给予早期肠内营养(早期肠内营养组)。所有其他治疗均相同。通过6小时尿乳果糖(L)和鼠李糖(R)回收率(%L、%R)及L/R回收率评估肠道通透性。通过粪便α1-蛋白酶抑制剂浓度(α1-PI)对肠道蛋白质丢失进行定量。早期肠内营养组在行为、食欲、呕吐和腹泻恢复正常的中位时间上,每个变量均比禁食组短1天。禁食组体重自入院后增加不显著(第3天:2.5±2.8%;第6天:4.3±2.3%;均值±标准误),而早期肠内营养组体重显著增加(第3天:8.1±2.7%;第6天:9.7±2.1%)。在整个研究过程中,两组的平均尿%L均升高,%R降低,L/R回收率升高。早期肠内营养组乳果糖回收率降低(入院时:22.6±8.0%;第6天:17.9±2.3%),禁食组升高(入院时:11.0±2.6%;第6天:22.5±4.6%,P = 0.035)。两组粪便α1-PI均高于参考值且逐渐下降。两组间%R、L/R比值或α1-PI无显著差异。13只禁食犬和所有早期肠内营养组犬存活(P = 0.48)。早期肠内营养组临床改善更早且体重显著增加。与禁食组相比,早期肠内营养组显著降低的%L可能反映了肠道屏障功能改善,这可能限制细菌或内毒素移位。

相似文献

2
Update on Canine Parvoviral Enteritis.
Vet Clin North Am Small Anim Pract. 2020 Nov;50(6):1307-1325. doi: 10.1016/j.cvsm.2020.07.008. Epub 2020 Sep 2.
3
Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial.
Vet Microbiol. 2002 Oct 22;89(2-3):115-27. doi: 10.1016/s0378-1135(02)00173-6.
4
Haemostatic changes associated with fluid resuscitation in canine parvoviral enteritis.
J S Afr Vet Assoc. 2020 Jul 29;91(0):e1-e9. doi: 10.4102/jsava.v91i0.2005.
5
Effect of parvoviral enteritis on plasma citrulline concentration in dogs.
J Vet Intern Med. 2011 Mar-Apr;25(2):215-21. doi: 10.1111/j.1939-1676.2010.0671.x. Epub 2011 Jan 31.
6
The central role of chloride in the metabolic acid-base changes in canine parvoviral enteritis.
Vet J. 2014 Apr;200(1):152-6. doi: 10.1016/j.tvjl.2014.01.017. Epub 2014 Feb 4.
7
Assessing the Efficacy of Maropitant Versus Ondansetron in the Treatment of Dogs with Parvoviral Enteritis.
J Am Anim Hosp Assoc. 2018 Nov/Dec;54(6):338-343. doi: 10.5326/JAAHA-MS-6650. Epub 2018 Oct 1.
8
Prognostic indicators at presentation for canine parvoviral enteritis: 322 cases (2001-2018).
J Vet Emerg Crit Care (San Antonio). 2021 May;31(3):402-413. doi: 10.1111/vec.13052. Epub 2021 Mar 31.
9
Palatability and Clinical Effects of an Oral Recuperation Fluid During the Recovery of Dogs With Suspected Parvoviral Enteritis.
Top Companion Anim Med. 2016 Jun;31(2):68-72. doi: 10.1053/j.tcam.2016.08.001. Epub 2016 Aug 6.
10
Factors affecting the occurrence, duration of hospitalization and final outcome in canine parvovirus infection.
Res Vet Sci. 2010 Oct;89(2):174-8. doi: 10.1016/j.rvsc.2010.02.013. Epub 2010 Mar 29.

引用本文的文献

1
Prognostic Roles of Trace Element and Cobalamin Concentrations in Dogs With Parvoviral Enteritis.
J Vet Intern Med. 2025 Mar-Apr;39(2):e70046. doi: 10.1111/jvim.70046.
3
Tolerability of naso-esophageal feeding tubes in dogs and cats at home: Retrospective review of 119 cases.
J Vet Intern Med. 2023 Nov-Dec;37(6):2315-2321. doi: 10.1111/jvim.16732. Epub 2023 Oct 25.
4
Immunoinformatics for Novel Multi-Epitope Vaccine Development in Canine Parvovirus Infections.
Biomedicines. 2023 Aug 2;11(8):2180. doi: 10.3390/biomedicines11082180.
5
Serum cobalamin and methylmalonic acid concentrations in juvenile dogs with parvoviral enteritis or other acute enteropathies.
J Vet Intern Med. 2023 Jul-Aug;37(4):1368-1375. doi: 10.1111/jvim.16736. Epub 2023 May 16.
6
Coagulation Abnormalities in Dogs with Parvoviral Enteritis.
Vet Sci. 2023 Jan 5;10(1):41. doi: 10.3390/vetsci10010041.
9
Update on Canine Parvoviral Enteritis.
Vet Clin North Am Small Anim Pract. 2020 Nov;50(6):1307-1325. doi: 10.1016/j.cvsm.2020.07.008. Epub 2020 Sep 2.
10
Acute Diarrhea in Dogs: Current Management and Potential Role of Dietary Polyphenols Supplementation.
Antioxidants (Basel). 2020 Aug 9;9(8):725. doi: 10.3390/antiox9080725.

本文引用的文献

2
Retrospective evaluation of partial parenteral nutrition in dogs and cats.
J Vet Intern Med. 2002 Jul-Aug;16(4):440-5. doi: 10.1892/0891-6640(2002)016<0440:reoppn>2.3.co;2.
5
Immunonutrition in the critically ill: a systematic review of clinical outcome.
Crit Care Med. 1999 Dec;27(12):2799-805. doi: 10.1097/00003246-199912000-00032.
8
Effect of critical illness and nutritional support on mucosal mass and function.
Clin Nutr. 1998 Jun;17(3):99-105. doi: 10.1016/s0261-5614(98)80002-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验